Drug Channels

MARCH 28, 2024

Today’s guest post comes from Bill Dupere, SVP of Product Development & Partnerships at Mercalis. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights.

Marketing 98

Marketing Science Therapies Production 98

Drug Patent Watch

JUNE 16, 2021

Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. The post New patent for Gilead Sciences drug VEKLURY appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier. There are eight….

Science 98

Science Drugs Marketing 98

Drug Patent Watch

AUGUST 27, 2021

Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. The post New patent for Gilead Sciences drug EPCLUSA appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier. There are twenty-six….

Science 98

Science Drugs Marketing 98

Drug Target Review

DECEMBER 20, 2024

These innovations have started to shift industry perceptions, positioning AI as a transformative tool that could alter how drugs are developed, tested, and brought to market. As Smith puts it, “now the viewpoint is that computational science is very powerful, and these AI/ML methods are going to be transformative in a lot of ways.”

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

sptlabtech

MARCH 20, 2024

By optimizing common laboratory tasks and processes, lab automation continues to demonstrate its value to the life science community. In drug discovery , automated platforms facilitate high-throughput screening of therapeutic candidates, accelerating the discovery process and bringing life-saving treatments to market more quickly.

Science 106

Science Laboratories Research Regulations 106

National Institute on Drug Abuse: Nora's Blog

NOVEMBER 4, 2024

Improving community engagement in addiction science mfleming Mon, 11/04/2024 - 19:11 Nora's Blog November 12, 2024 Image ©Getty Images/ MStudioImages Medical research can sometimes become disconnected from the interests and needs of the people it is intended to serve. Surveillance is one example.

Science 85

Science Research Treatment Drugs 85

Fierce BioTech

MARCH 3, 2025

3 Ways to Ensure Your Marketing Fills Your Life Science BD Pipeline How can you keep your pipeline full of qualified leads when nobody seems interested in buying? The answer: a pipeline-supporting marketing plan that includes proven tools, well-executed tactics, and a clear strategy.

Marketing 52

Marketing Science 52

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. “Pharmacognosy is the bridge between traditional medicine and modern pharmaceutical science, offering a treasure trove of potential new drugs waiting to be discovered.”

Drugs 96

Drugs Drug Development Pharmaceuticals Production 96

Science Daily: Pharmacology News

AUGUST 16, 2024

With new medications on the market or in the works for Alzheimer's disease and other kinds of dementia, a new study suggests that getting the diagnosis needed to access these new treatments may depend on where you live.

Treatment 322

Treatment Disease Marketing 322

Science Daily: Pharmacology News

AUGUST 8, 2024

A research team has recently developed a novel artificial compound eye system that is not only more cost-effective, but demonstrates a sensitivity at least twice that of existing market products in small areas.

Production 333

Production Marketing Research 333

Science Daily: Pharmacology News

AUGUST 1, 2024

What if the 'Market Economy' always existed? Archaeologists tried to answer this question by researching how much Bronze Age people used to spend to sustain their daily lives. Their results show that, starting at least 3,500 years ago, the spending habits of prehistoric Europeans were not substantially different from what they are today.

Marketing 321

Marketing Research 321

PPD

JANUARY 15, 2025

Accelerate customer speed to market With a modern and integrated user experience, AI solutions put the right data and insights into the right hands in real time. As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster.

Clinical Trials 95

Clinical Trials Trials Clinical Research Drug Development 95

LifeSciVC

NOVEMBER 28, 2023

Market conditions like this are demoralizing in the worst way. Furthermore, to make matters even more complicated, that same summer, markets had already turned sour, and the sentiment was darkening by the day. The biotech equity markets had effectively shut off the idea of an IPO (which was one of several paths we had mapped out).

Marketing 91

Marketing FDA Pharma Companies Government 91

Drug Channels

MARCH 19, 2023

This annual event has become a must-attend for pricing and contracting professionals in the life sciences industry with seasoned leaders and forward-thinking strategies on display. NEW THIS YEAR!

Science 75

Science Government Pharmaceuticals Drugs 75

Science Daily: Pharmacology News

OCTOBER 3, 2024

They argue that subsidies can alter market pressures, leading to unintended consequences that not only perpetuate harmful subsidies over time but also diminish the overall effectiveness of those intended to promote environmental sustainability.

Government 302

Government Marketing 302

Drug Patent Watch

JULY 8, 2024

Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this…

Science 59

Science Drugs Marketing 59

Fierce BioTech

MARCH 31, 2025

Beyond the Science: Accelerating Biotech Success dwunderlin Mon, 03/31/2025 - 16:17 Wed, 05/14/2025 - 11:00 Resource Type Webinar Vik Chawla Paul Holmes Biotech success isnt just about great scienceits about building a compelling commercial narrative from day one. Click here to login. Listing Image SyneosHealth_ListingLogo_250x190.png

Science 52

Science Licensing Licensing Marketing 52

FDA Law Blog: Biosimilars

JUNE 27, 2023

James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. Karst Awarded WWL: Life Sciences 2023 Global Elite Thought Leader HP&M Director Kurt R. Karst was named by Who’s Who Legal: Life Sciences 2023 as one of only 14 “Global Elite Thought Leaders.” HP&M’s Kurt R.

Science 81

Science FDA Approval FDA Drug Development 81

Science Daily: Pharmacology News

MARCH 6, 2024

The advance holds promise for bringing more energy dense and low-cost Li-S batteries closer to market. Engineers developed a cathode material for lithium-sulfur (Li-S) batteries that is healable and highly conductive, overcoming longstanding challenges of traditional sulfur cathodes.

Engineering 305

Engineering Marketing 305

Science Daily: Pharmacology News

APRIL 24, 2024

These semiconducting materials, known as copper oxides, are cheap, abundant and non-toxic, but their performance does not come close to silicon, which dominates the semiconductor market.

Engineering 319

Engineering Marketing Research 319

Drug Patent Watch

MARCH 11, 2024

Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are nineteen… The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

FEBRUARY 8, 2024

Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are thirteen… The post New patent for Gilead Sciences drug VEKLURY appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

JANUARY 15, 2024

Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are six patents… The post New patent for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

DECEMBER 13, 2023

Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are six patents… The post New patent for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

DECEMBER 13, 2023

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Myovant Sciences and is included in one NDA. There are eight patents… The post New patent for Myovant Sciences drug ORGOVYX appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

OCTOBER 26, 2023

Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are four patents… The post New patent for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

OCTOBER 26, 2023

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Myovant Sciences and is included in one NDA. There are seven patents… The post New patent for Myovant Sciences drug ORGOVYX appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

OCTOBER 5, 2023

Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are eleven… The post New patent for Gilead Sciences drug BIKTARVY appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers.

Science 59

Science Drugs Marketing 59

H1 Blog

NOVEMBER 21, 2023

The life sciences industry, characterized by stringent regulations, vast data sets, and the critical nature of its decisions, is increasingly turning to Artificial Intelligence (AI) for solutions. However, before integrating an AI product into a life sciences workflow , it is crucial to evaluate its effectiveness and reliability rigorously.

Science 64

Science Production Clinical Trials Regulations 64

Fierce BioTech

JANUARY 28, 2025

The Oncology Market: 2024 Year in Review This paper reviews key developments in the oncology market during 2024 and outlines what they mean for the future. jpiatt Tue, 01/28/2025 - 14:36 This paper reviews key developments in the oncology market during 2024 and outlines what they mean for the future.

Marketing 52

Marketing Science 52

Drug Patent Watch

FEBRUARY 16, 2024

Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are six patents… The post New patent expiration for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

JANUARY 27, 2024

Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are six patents… The post New patent expiration for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

JANUARY 12, 2024

Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are eleven… The post New patent expiration for Gilead Sciences drug STRIBILD appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

JANUARY 12, 2024

Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are eight… The post New patent expiration for Gilead Sciences drug COMPLERA appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

Drug Patent Watch

JANUARY 12, 2024

Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. There are seven patents… The post New patent expiration for Gilead Sciences drug ATRIPLA appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Science 59

Science Drugs Marketing 59

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2023

HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Hyman, Phelps & McNamara, P.C. (HP&M),

Marketing 59

Marketing Compliance Science FDA 59

Drug Patent Watch

APRIL 24, 2024

Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four… Source

Science 59

Science Drugs Marketing 59